Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$223.48 USD
+0.13 (0.06%)
Updated May 25, 2022 04:00 PM ET
After-Market: $223.35 -0.13 (-0.06%) 6:12 PM ET
3-Hold of 5 3
B Value A Growth D Momentum B VGM
Industry / Sector Report
Industry : Medical Services
Zacks Industry Rank
Bottom 24% (192 out of 253)Zacks Sector Rank
Top 50% (8 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.41 | 1.51 | 9.99 |
Current Quarter Estimate | 2.83 | 1.48 | 54.00 |
Year Ago Quarter Estimate | 2.61 | 0.51 | 45.95 |
Next Quarter Estimate | 2.94 | 1.51 | 59.00 |
Next Year Estimate | 13.39 | 8.09 | 260.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 12.69 | 2.50 | 8.93 |
Next Year | 15.13 | 17.30 | 14.64 |
Last 5 Years | 17.70 | 12.20 | 13.40 |
Next 5 Years | 14.00 | 16.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 21.17 | 17.34 |
Price/Book (MRQ) | 4.34 | 2.49 |
Price/Cash Flow (MRFY) | 14.16 | 14.75 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 11.64% | -3.85% |
Return on Equity (TTM) | 21.90% | -5.69% |
Debt to Equity (MRQ) | 1.02 | 32.21 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.